{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,3]],"date-time":"2025-12-03T19:46:23Z","timestamp":1764791183418,"version":"3.46.0"},"reference-count":47,"publisher":"Archives of Pathology and Laboratory Medicine","issue":"2","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2015,2,1]]},"abstract":"<jats:sec>\n                    <jats:title>Context<\/jats:title>\n                    <jats:p>Women who have been treated for high-grade cervical or vaginal intraepithelial neoplasia (CIN or VAIN) or invasive carcinoma are at risk for recurrent\/persistent disease and require long-term monitoring. The role of human papillomavirus (HPV) testing in this setting is unclear.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Objective<\/jats:title>\n                    <jats:p>To evaluate the clinical performance of the Hybrid Capture 2 (HC2) HPV test for recurrent\/residual high-grade CIN or VAIN in patients with a posttherapy abnormal squamous cells of undetermined significance (ASC-US) Papanicolaou test result.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Design<\/jats:title>\n                    <jats:p>We reviewed the follow-up data on 100 patients who had an ASC-US Papanicolaou test and HC2 HPV results after treatment for high-grade CIN\/VAIN or carcinoma. Human papillomavirus genotyping was performed for women with a negative HC2 result whose follow-up biopsy revealed CIN\/VAIN 2+.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>The patients' mean age was 47 years. The HC2 test result was positive in 33% of the patients. Follow-up biopsy was available for 17 of these patients (52%) and for 25 of the 67 patients (37%) with a negative HC2 result. A total of 5 of the patients (29%) with a positive HC2 result and 2 of the patients (8%) with a negative HC2 result had CIN\/VAIN 3 on follow-up biopsy, a statistically insignificant difference (P = .10). Human papillomavirus 16\/18 genotypes were detected in the CIN\/VAIN 2+ lesions of 5 patients with a negative HC2 result.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>HC2 yielded a false-negative rate of 8% for CIN 3. HC2 testing therefore may not be sufficient for triage of patients with an ASC-US Papanicolaou test result. Patients with ASC-US during long-term posttherapy follow-up need close monitoring, with colposcopic evaluation if clinically indicated.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.5858\/arpa.2013-0291-oa","type":"journal-article","created":{"date-parts":[[2015,1,22]],"date-time":"2015-01-22T12:16:21Z","timestamp":1421928981000},"page":"219-224","source":"Crossref","is-referenced-by-count":4,"title":["Clinical Performance of Hybrid Capture 2 Human Papillomavirus Testing for Recurrent High-Grade Cervical\/Vaginal Intraepithelial Neoplasm in Patients With an ASC-US Papanicolaou Test Result During Long-Term Posttherapy Follow-up Monitoring"],"prefix":"10.5858","volume":"139","author":[{"given":"Andrea Diaz","family":"De Vivar","sequence":"first","affiliation":[{"name":"From the Department of Pathology, The University of Texas MD Anderson Cancer Center, Houston (Drs Diaz De Vivar, Gong, Staerkel, and Guo, Mss Dawlett and Jack, and Mr Wang); and the Department of Pathology, Texas Children's Hospital Pavilion for Women, Houston (Dr Diaz De Vivar)."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marilyn","family":"Dawlett","sequence":"additional","affiliation":[{"name":"From the Department of Pathology, The University of Texas MD Anderson Cancer Center, Houston (Drs Diaz De Vivar, Gong, Staerkel, and Guo, Mss Dawlett and Jack, and Mr Wang); and the Department of Pathology, Texas Children's Hospital Pavilion for Women, Houston (Dr Diaz De Vivar)."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jian-Ping","family":"Wang","sequence":"additional","affiliation":[{"name":"From the Department of Pathology, The University of Texas MD Anderson Cancer Center, Houston (Drs Diaz De Vivar, Gong, Staerkel, and Guo, Mss Dawlett and Jack, and Mr Wang); and the Department of Pathology, Texas Children's Hospital Pavilion for Women, Houston (Dr Diaz De Vivar)."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Annie","family":"Jack","sequence":"additional","affiliation":[{"name":"From the Department of Pathology, The University of Texas MD Anderson Cancer Center, Houston (Drs Diaz De Vivar, Gong, Staerkel, and Guo, Mss Dawlett and Jack, and Mr Wang); and the Department of Pathology, Texas Children's Hospital Pavilion for Women, Houston (Dr Diaz De Vivar)."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yun","family":"Gong","sequence":"additional","affiliation":[{"name":"From the Department of Pathology, The University of Texas MD Anderson Cancer Center, Houston (Drs Diaz De Vivar, Gong, Staerkel, and Guo, Mss Dawlett and Jack, and Mr Wang); and the Department of Pathology, Texas Children's Hospital Pavilion for Women, Houston (Dr Diaz De Vivar)."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gregg","family":"Staerkel","sequence":"additional","affiliation":[{"name":"From the Department of Pathology, The University of Texas MD Anderson Cancer Center, Houston (Drs Diaz De Vivar, Gong, Staerkel, and Guo, Mss Dawlett and Jack, and Mr Wang); and the Department of Pathology, Texas Children's Hospital Pavilion for Women, Houston (Dr Diaz De Vivar)."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ming","family":"Guo","sequence":"additional","affiliation":[{"name":"From the Department of Pathology, The University of Texas MD Anderson Cancer Center, Houston (Drs Diaz De Vivar, Gong, Staerkel, and Guo, Mss Dawlett and Jack, and Mr Wang); and the Department of Pathology, Texas Children's Hospital Pavilion for Women, Houston (Dr Diaz De Vivar)."}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"3906","reference":[{"issue":"1","key":"2020081222315749500_i1543-2165-139-2-219-b01","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1016\/j.ygyno.2004.03.036","article-title":"HPV DNA test and Pap smear in detection of residual and recurrent disease following loop electrosurgical excision procedure of high-grade cervical intraepithelial neoplasia","volume":"94","author":"Sarian","year":"2004","journal-title":"Gynecol Oncol"},{"issue":"2","key":"2020081222315749500_i1543-2165-139-2-219-b02","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1111\/j.1525-1438.2006.00404.x","article-title":"Long-term follow-up after large-loop excision of the transformation zone: evaluation of 22 years treatment of high-grade cervical intraepithelial neoplasia","volume":"16","author":"van Hamont","year":"2006","journal-title":"Int J Gynecol Cancer"},{"issue":"5","key":"2020081222315749500_i1543-2165-139-2-219-b03","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1097\/00006250-199811000-00001","article-title":"A randomized clinical trial of cryotherapy, laser vaporization, and loop electrosurgical excision for treatment of squamous intraepithelial lesions of the cervix","volume":"92","author":"Mitchell","year":"1998","journal-title":"Obstet Gynecol"},{"issue":"4","key":"2020081222315749500_i1543-2165-139-2-219-b04","first-page":"199","article-title":"Management of cervical neoplasia: a 13-year experience with cryotherapy and laser","volume":"5","author":"Persad","year":"2001","journal-title":"J Low Genit Tract Dis"},{"issue":"10","key":"2020081222315749500_i1543-2165-139-2-219-b05","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1093\/jnci\/djp089","article-title":"Cervical intraepithelial neoplasia outcomes after treatment: long-term follow-up from the British Columbia Cohort Study","volume":"101","author":"Melnikow","year":"2009","journal-title":"J Natl Cancer Inst"},{"issue":"8","key":"2020081222315749500_i1543-2165-139-2-219-b06","doi-asserted-by":"crossref","first-page":"2048","DOI":"10.1002\/ijc.21604","article-title":"Long-term risk of invasive cervical cancer after treatment of squamous cervical intraepithelial neoplasia","volume":"118","author":"Soutter","year":"2006","journal-title":"Int J Cancer"},{"issue":"7526","key":"2020081222315749500_i1543-2165-139-2-219-b07","doi-asserted-by":"crossref","first-page":"1183","DOI":"10.1136\/bmj.38663.459039.7C","article-title":"Risk of cervical and other cancers after treatment of cervical intraepithelial neoplasia: retrospective cohort study","volume":"331","author":"Kalliala","year":"2005","journal-title":"BMJ"},{"issue":"4","key":"2020081222315749500_i1543-2165-139-2-219-b08","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1016\/j.ajog.2007.07.050","article-title":"2006 consensus guidelines for the management of women with cervical intraepithelial neoplasia or adenocarcinoma in situ","volume":"197","author":"Wright","year":"2007","journal-title":"Am J Obstet Gynecol"},{"issue":"3","key":"2020081222315749500_i1543-2165-139-2-219-b09","doi-asserted-by":"crossref","first-page":"147","DOI":"10.3322\/caac.21139","article-title":"American Cancer Society, American Society for Colposcopy and Cervical Pathology, and American Society for Clinical Pathology screening guidelines for the prevention and early detection of cervical cancer","volume":"62","author":"Saslow","year":"2012","journal-title":"CA Cancer J Clin"},{"issue":"5","key":"2020081222315749500_i1543-2165-139-2-219-b10","first-page":"1514","article-title":"Practice Bulletin No. 131: clinical management guidelines for obstetrician-gynecologists","volume":"120","year":"2012","journal-title":"Obstet Gynecol"},{"issue":"5","key":"2020081222315749500_i1543-2165-139-2-219-b11","first-page":"S1","article-title":"updated consensus guidelines for the management of abnormal cervical cancer screening tests and cancer precursors","volume":"17","author":"Massad","year":"2012","journal-title":"J Low Genit Tract Dis"},{"issue":"suppl 1","key":"2020081222315749500_i1543-2165-139-2-219-b12","doi-asserted-by":"crossref","first-page":"S7","DOI":"10.1016\/j.ygyno.2005.07.033","article-title":"Clinical utility of HPV-DNA detection: triage of minor cervical lesions, follow-up of women treated for high-grade CIN: an update of pooled evidence","volume":"99","author":"Arbyn","year":"2005","journal-title":"Gynecol Oncol"},{"issue":"2","key":"2020081222315749500_i1543-2165-139-2-219-b13","doi-asserted-by":"crossref","first-page":"500","DOI":"10.1016\/j.ygyno.2012.01.015","article-title":"High-risk human papillomavirus testing versus cytology in predicting post-treatment disease in women treated for high-grade cervical disease: a systematic review and meta-analysis","volume":"125","author":"Kocken","year":"2012","journal-title":"Gynecol Oncol"},{"issue":"4","key":"2020081222315749500_i1543-2165-139-2-219-b14","doi-asserted-by":"crossref","first-page":"422.e1","DOI":"10.1016\/j.ajog.2008.11.031","article-title":"Posttreatment human papillomavirus testing for recurrent cervical intraepithelial neoplasia: a systematic review","volume":"200","author":"Chan","year":"2009","journal-title":"Am J Obstet Gynecol"},{"issue":"7","key":"2020081222315749500_i1543-2165-139-2-219-b15","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1097\/00006254-200407000-00024","article-title":"HPV testing and monitoring of women after treatment of CIN 3: review of the literature and meta-analysis","volume":"59","author":"Zielinski","year":"2004","journal-title":"Obstet Gynecol Surv"},{"issue":"2","key":"2020081222315749500_i1543-2165-139-2-219-b16","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1016\/j.ctrv.2003.07.008","article-title":"The role of HPV DNA testing in the follow-up period after treatment for CIN: a systematic review of the literature","volume":"30","author":"Paraskevaidis","year":"2004","journal-title":"Cancer Treat Rev"},{"issue":"1","key":"2020081222315749500_i1543-2165-139-2-219-b17","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1002\/ijc.26349","article-title":"Long-term risk of recurrent cervical human papillomavirus infection and precancer and cancer following excisional treatment","volume":"131","author":"Kreimer","year":"2012","journal-title":"Int J Cancer"},{"issue":"11","key":"2020081222315749500_i1543-2165-139-2-219-b18","doi-asserted-by":"crossref","first-page":"1303","DOI":"10.1111\/j.1471-0528.2006.01063.x","article-title":"Prediction of recurrence after treatment for high-grade cervical intraepithelial neoplasia: the role of human papillomavirus testing and age at conisation","volume":"113","author":"Verguts","year":"2006","journal-title":"BJOG"},{"issue":"2","key":"2020081222315749500_i1543-2165-139-2-219-b19","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1016\/j.ygyno.2006.04.016","article-title":"Pre- and post-conization high-risk HPV testing predicts residual\/recurrent disease in patients treated for CIN 2\u20133","volume":"103","author":"Alonso","year":"2006","journal-title":"Gynecol Oncol"},{"issue":"5","key":"2020081222315749500_i1543-2165-139-2-219-b20","doi-asserted-by":"crossref","first-page":"908","DOI":"10.1158\/1055-9965.EPI-05-0845","article-title":"Human papillomavirus testing following loop electrosurgical excision procedure identifies women at risk for posttreatment cervical intraepithelial neoplasia grade 2 or 3 disease","volume":"15","author":"Kreimer","year":"2006","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"issue":"2","key":"2020081222315749500_i1543-2165-139-2-219-b21","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1111\/j.1479-828X.2009.01132.x","article-title":"Testing for high risk human papilloma virus in the initial follow-up of women treated for high-grade squamous intraepithelial lesions","volume":"50","author":"Smart","year":"2010","journal-title":"Aust N Z J Obstet Gynaecol"},{"issue":"2","key":"2020081222315749500_i1543-2165-139-2-219-b22","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1016\/j.ajog.2006.02.047","article-title":"Predicting absolute risk of CIN3 during post-colposcopic follow-up: results from the ASCUS-LSIL Triage Study (ALTS)","volume":"195","author":"Walker","year":"2006","journal-title":"Am J Obstet Gynecol"},{"issue":"16","key":"2020081222315749500_i1543-2165-139-2-219-b23","doi-asserted-by":"crossref","first-page":"2114","DOI":"10.1001\/jama.287.16.2114","article-title":"The 2001 Bethesda System: terminology for reporting results of cervical cytology","volume":"287","author":"Solomon","year":"2002","journal-title":"JAMA"},{"issue":"1\u20132","key":"2020081222315749500_i1543-2165-139-2-219-b24","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jviromet.2006.10.004","article-title":"Quality assurance of genotyping array for detection and typing of human papillomavirus","volume":"140","author":"Lin","year":"2007","journal-title":"J Virol Methods"},{"issue":"3","key":"2020081222315749500_i1543-2165-139-2-219-b25","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1002\/ijc.10080","article-title":"Persistent human papillomavirus infection and smoking increase risk of failure of treatment of cervical intraepithelial neoplasia (CIN)","volume":"98","author":"Acladious","year":"2002","journal-title":"Int J Cancer"},{"issue":"2","key":"2020081222315749500_i1543-2165-139-2-219-b26","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1097\/PGP.0b013e3181891459","article-title":"HPV determination in the control after LEEP due to CIN II-III: prospective study and predictive model","volume":"28","author":"Fuste","year":"2009","journal-title":"Int J Gynecol Pathol"},{"issue":"4","key":"2020081222315749500_i1543-2165-139-2-219-b27","doi-asserted-by":"crossref","first-page":"706","DOI":"10.1111\/j.1447-0756.2008.00989.x","article-title":"High-risk human papillomavirus testing for monitoring patients treated for high-grade cervical intraepithelial neoplasia","volume":"35","author":"Jeong","year":"2009","journal-title":"J Obstet Gynaecol Res"},{"issue":"1","key":"2020081222315749500_i1543-2165-139-2-219-b28","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1097\/AOG.0b013e3181e3e719","article-title":"The age-specific relationships of abnormal cytology and human papillomavirus DNA results to the risk of cervical precancer and cancer","volume":"116","author":"Castle","year":"2010","journal-title":"Obstet Gynecol"},{"issue":"6","key":"2020081222315749500_i1543-2165-139-2-219-b29","doi-asserted-by":"crossref","first-page":"1325","DOI":"10.1097\/01.AOG.0000263461.71732.40","article-title":"Risk of precancer and follow-up management strategies for women with human papillomavirus-negative atypical squamous cells of undetermined significance","volume":"109","author":"Safaeian","year":"2007","journal-title":"Obstet Gynecol"},{"issue":"5","key":"2020081222315749500_i1543-2165-139-2-219-b30","doi-asserted-by":"crossref","first-page":"S78","DOI":"10.1097\/LGT.0b013e31828543c5","article-title":"Five-year risk of recurrence after treatment of CIN 2, CIN 3, or AIS: performance of HPV and Pap cotesting in posttreatment management","volume":"17","author":"Katki","year":"2013","journal-title":"J Low Genit Tract Dis"},{"issue":"3","key":"2020081222315749500_i1543-2165-139-2-219-b31","doi-asserted-by":"crossref","first-page":"468","DOI":"10.1309\/AJCPZ5JY6FCVNMOT","article-title":"High-risk human papillomavirus testing in women with ASC-US cytology: results from the ATHENA HPV study","volume":"135","author":"Stoler","year":"2011","journal-title":"Am J Clin Pathol"},{"issue":"2","key":"2020081222315749500_i1543-2165-139-2-219-b32","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1309\/AJCPGW1V2BBWMOCX","article-title":"The interplay of age stratification and HPV testing on the predictive value of ASC-US cytology: results from the ATHENA HPV study","volume":"137","author":"Stoler","year":"2012","journal-title":"Am J Clin Pathol"},{"issue":"2","key":"2020081222315749500_i1543-2165-139-2-219-b33","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1016\/j.ygyno.2010.04.013","article-title":"Clinical validation of the Cervista HPV HR and 16\/18 genotyping tests for use in women with ASC-US cytology","volume":"118","author":"Einstein","year":"2010","journal-title":"Gynecol Oncol"},{"issue":"2","key":"2020081222315749500_i1543-2165-139-2-219-b34","doi-asserted-by":"crossref","first-page":"86","DOI":"10.3802\/jgo.2009.20.2.86","article-title":"Role of high risk-human papilloma virus test in the follow-up of patients who underwent conization of the cervix for cervical intraepithelial neoplasia","volume":"20","author":"Park","year":"2009","journal-title":"J Gynecol Oncol"},{"issue":"20","key":"2020081222315749500_i1543-2165-139-2-219-b35","doi-asserted-by":"crossref","first-page":"10112","DOI":"10.1158\/0008-5472.CAN-06-1812","article-title":"Relationships of human papillomavirus type, qualitative viral load, and age with cytologic abnormality","volume":"66","author":"Kovacic","year":"2006","journal-title":"Cancer Res"},{"issue":"4","key":"2020081222315749500_i1543-2165-139-2-219-b36","doi-asserted-by":"crossref","first-page":"889","DOI":"10.1002\/ijc.23824","article-title":"Post-treatment CIN: randomised clinical trial using hrHPV testing for prediction of residual\/recurrent disease","volume":"124","author":"Bais","year":"2009","journal-title":"Int J Cancer"},{"issue":"1","key":"2020081222315749500_i1543-2165-139-2-219-b37","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1016\/j.jviromet.2006.05.033","article-title":"Recovery of human papillomavirus nucleic acids from liquid-based cytology media","volume":"137","author":"Powell","year":"2006","journal-title":"J Virol Methods"},{"issue":"8","key":"2020081222315749500_i1543-2165-139-2-219-b38","doi-asserted-by":"crossref","first-page":"2702","DOI":"10.1128\/JCM.00759-13","article-title":"Long-term stability of human genomic and human papillomavirus DNA stored in BD SurePath and Hologic PreservCyt liquid-based cytology media","volume":"51","author":"Agreda","year":"2013","journal-title":"J Clin Microbiol"},{"issue":"5","key":"2020081222315749500_i1543-2165-139-2-219-b39","doi-asserted-by":"crossref","first-page":"606","DOI":"10.5858\/arpa.2012-0149-CP","article-title":"The College of American Pathologists' first 3 years' experience with high-risk human papillomavirus proficiency testing for cytology and other laboratories","volume":"137","author":"Moriarty","year":"2013","journal-title":"Arch Pathol Lab Med"},{"issue":"6","key":"2020081222315749500_i1543-2165-139-2-219-b40","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1002\/cncy.20177","article-title":"Comparison of ThinPrep and SurePath liquid-based cytology and subsequent human papillomavirus DNA testing in China","volume":"119","author":"Zhao","year":"2011","journal-title":"Cancer Cytopathol"},{"issue":"6","key":"2020081222315749500_i1543-2165-139-2-219-b41","doi-asserted-by":"crossref","first-page":"468","DOI":"10.1002\/cncr.22285","article-title":"Human papillomavirus testing using hybrid capture II with SurePath collection: initial evaluation and longitudinal data provide clinical validation for this method","volume":"108","author":"Ko","year":"2006","journal-title":"Cancer"},{"issue":"5","key":"2020081222315749500_i1543-2165-139-2-219-b42","first-page":"318","article-title":"Hybrid capture 2 human papillomavirus DNA testing for women with atypical squamous cells of undetermined significance Papanicolaou results in SurePath and ThinPrep specimens","volume":"117","author":"Siddiqi","year":"2009","journal-title":"Cancer"},{"issue":"1","key":"2020081222315749500_i1543-2165-139-2-219-b43","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1309\/AJCP4DF7ACLBFFGY","article-title":"Follow-up outcomes of a large cohort of low-risk women with negative imaged liquid-based cytology and negative HPV test results","volume":"139","author":"Zhao","year":"2013","journal-title":"Am J Clin Pathol"},{"issue":"11","key":"2020081222315749500_i1543-2165-139-2-219-b44","doi-asserted-by":"crossref","first-page":"849","DOI":"10.1097\/OLQ.0b013e318064c8c5","article-title":"A comparison of cervical and vaginal human papillomavirus","volume":"34","author":"Castle","year":"2007","journal-title":"Sex Transm Dis"},{"issue":"3","key":"2020081222315749500_i1543-2165-139-2-219-b45","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1309\/AJCP9TO1OMXLDDPI","article-title":"Correlation of histopathologic\/cytologic follow-up findings with vaginal ASC-US and ASC-H Papanicolaou test and HPV test results","volume":"137","author":"Bansal","year":"2012","journal-title":"Am J Clin Pathol"},{"issue":"1","key":"2020081222315749500_i1543-2165-139-2-219-b46","doi-asserted-by":"crossref","first-page":"72.e1","DOI":"10.1016\/j.ajog.2010.01.063","article-title":"Significance of human papillomavirus genotyping with high-grade cervical intraepithelial neoplasia treated by a loop electrosurgical excision procedure","volume":"203","author":"Kang","year":"2013","journal-title":"Am J Obstet Gynecol"},{"issue":"7","key":"2020081222315749500_i1543-2165-139-2-219-b47","doi-asserted-by":"crossref","first-page":"1668","DOI":"10.1158\/1055-9965.EPI-09-1286","article-title":"Comparison of measurements of human papillomavirus persistence for postcolposcopic surveillance for cervical precancerous lesions","volume":"19","author":"Gage","year":"2010","journal-title":"Cancer Epidemiol Biomarkers Prev"}],"container-title":["Archives of Pathology &amp; Laboratory Medicine"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/meridian.allenpress.com\/aplm\/article-pdf\/139\/2\/219\/1613131\/arpa_2013-0291-oa.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"http:\/\/meridian.allenpress.com\/aplm\/article-pdf\/139\/2\/219\/1613131\/arpa_2013-0291-oa.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,12,3]],"date-time":"2025-12-03T19:36:52Z","timestamp":1764790612000},"score":1,"resource":{"primary":{"URL":"https:\/\/aplm.kglmeridian.com\/view\/journals\/arpa\/139\/2\/article-p219.xml"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,2,1]]},"references-count":47,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2015,2,1]]}},"URL":"https:\/\/doi.org\/10.5858\/arpa.2013-0291-oa","relation":{},"ISSN":["1543-2165","0003-9985"],"issn-type":[{"type":"electronic","value":"1543-2165"},{"type":"print","value":"0003-9985"}],"subject":[],"published":{"date-parts":[[2015,2,1]]}}}